Back to Trades
Mutz Christopher
HEAD OF RARE DISEASECIK 0001846487
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 1
- Active
- 2026
Mutz Christopher, HEAD OF RARE DISEASE, has filed 5 SEC reports (2026), all concentrated in ANI PHARMACEUTICALS INC (ANIP), totaling $3.2M in disclosed volume. Weighing $0 bought versus $1.1M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Mar 13 | ANIP ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Sell | $226.5K |
| Mar 10 | ANIP ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Sell | $424.6K |
| Mar 4 | ANIP ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Sell | $30.9K |
| Mar 2 | ANIP ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Grant | $1.6M |
| Feb 23 | ANIP ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Sell | $415.3K |
5 filings